hydralazine has been researched along with medroxyprogesterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cordasco, EM | 1 |
1 review(s) available for hydralazine and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for hydralazine and medroxyprogesterone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Pulmonary vascular disease--overview.
Topics: Angiography; Heparin; Humans; Hydralazine; Hypertension, Pulmonary; Lung; Lung Diseases, Obstructive; Lymphangiomyoma; Medroxyprogesterone; Oxygen Inhalation Therapy; Phlebography; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging; Terbutaline; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1983 |